Vibratory screening in pharmaceutical manufacturing is used to classify active pharmaceutical ingredients (APIs), screen excipients, size granulations, and remove contaminants to ensure product purity, dosage uniformity, and compliance with FDA cGMP requirements. Every tablet, capsule, powder, and suspension produced in a pharmaceutical facility depends on precise particle size control, and vibratory separators are the primary equipment used to achieve it.
How Is Vibratory Screening Used in Pharmaceutical Manufacturing?
Pharmaceutical production involves multiple screening steps, from raw material intake through finished product release. Vibratory screeners classify powders and granules into precise particle size fractions that directly affect how a drug dissolves, how uniformly it distributes in a blend, and how consistently it delivers the intended dose to a patient. In pharmaceutical manufacturing, screening is not merely a quality preference. It is a regulatory requirement documented in the batch record.
Unlike many industrial screening applications where slight variations in particle size are tolerable, pharmaceutical screening demands repeatability and traceability. Every screen used in production must have documented specifications, every batch must pass through validated screening parameters, and every deviation must be investigated and documented.
Common Pharmaceutical Screening Applications
- API classification: Separating active pharmaceutical ingredients into specified particle size fractions that determine dissolution rate, bioavailability, and dosage uniformity in the finished drug product
- Excipient screening: Removing agglomerates, foreign material, and oversized particles from binders, fillers, flow agents, and other excipient materials before blending
- Post-granulation sizing: Breaking down and classifying wet or dry granulations into the target particle size range required for tableting or capsule filling. This is one of the highest-volume screening operations in oral solid dosage manufacturing.
- Contamination removal and safety screening: Check-screening incoming raw materials and finished intermediates to detect and remove foreign particles, metal fragments, fiber, or any material that should not be present in a pharmaceutical product
- De-lumping and de-agglomeration: Breaking apart clumps that form during storage, transport, or processing of hygroscopic pharmaceutical powders
- Powder blend uniformity: Screening blended pharmaceutical powders to verify uniform particle size distribution before compression or encapsulation
What Mesh Sizes Are Used in Pharmaceutical Manufacturing?
Mesh size selection in pharmaceutical manufacturing is driven by the product formulation, the USP specifications for the drug product, and the specific unit operation being performed. The table below lists typical mesh ranges for common pharmaceutical screening applications.
Typical Mesh Ranges by Application
| Application | Typical Mesh Range | Approximate Particle Size | Screening Purpose |
|---|---|---|---|
| API classification (coarse) | 60 – 100 mesh | 250 – 150 μm | Size classification for dissolution control |
| API classification (fine) | 140 – 325 mesh | 106 – 45 μm | Fine classification for potent or micronized APIs |
| Excipient screening | 20 – 100 mesh | 850 – 150 μm | Agglomerate removal, quality assurance |
| Post-granulation sizing (wet) | 12 – 20 mesh | 1,700 – 850 μm | Coarse sizing after wet granulation |
| Post-granulation sizing (dry) | 16 – 30 mesh | 1,190 – 600 μm | Classification after dry granulation or milling |
| Safety / check screening | 10 – 30 mesh | 2,000 – 600 μm | Foreign particle detection and removal |
| Powder blend verification | 20 – 60 mesh | 850 – 250 μm | Blend uniformity confirmation before compression |
Pharmaceutical mesh sizes are often specified using USP sieve designations. For conversions between USP sieve numbers, mesh count, and micron measurements, refer to our Mesh Size Conversion Chart.
Material Considerations for Pharmaceutical Screens
316 stainless steel is the standard material for pharmaceutical vibratory screens. Its molybdenum content provides the corrosion resistance needed to withstand aggressive cleaning solvents, sanitizing agents, and the high-purity water systems used in pharmaceutical manufacturing. 316 SS screens can be electropolished to achieve the surface finish requirements specified by cGMP and USP standards.
For specialized pharmaceutical applications involving highly corrosive compounds, Hastelloy or other specialty alloy screens may be required. ScreenerKing can manufacture custom screens in specialty materials upon request.
What Are the Biggest Screening Challenges in Pharmaceutical Manufacturing?
Pharmaceutical screening operates under constraints that few other industries face. The combination of extreme purity requirements, stringent regulatory oversight, and the direct impact of particle size on drug product performance makes pharmaceutical vibratory screening one of the most exacting applications in the industry.
Preventing Cross-Contamination Between Products
Cross-contamination between drug products is the single most critical screening challenge in pharmaceutical manufacturing. When a facility produces multiple drug products on shared equipment, every trace of the previous product must be removed before the next batch begins. For vibratory screeners, this means complete disassembly, validated cleaning of all product contact surfaces, swab or rinse testing to confirm cleaning effectiveness, and documented reassembly.
The consequences of cross-contamination in pharmaceutical production are severe: product recall, patient safety risk, FDA warning letters, and potential facility shutdown. Many pharmaceutical operations address this risk by maintaining dedicated screen inventories for each product, color-coding screens by product line, and implementing rigorous screen management programs with full traceability from receipt through use and disposal.
Screen construction plays a direct role in cross-contamination prevention. Screens with smooth, crevice-free bonding, no exposed adhesives in the product zone, and surfaces that clean completely under validated procedures reduce the risk of residual product carry-over.
Achieving Particle Size Consistency for Dosage Uniformity
In pharmaceutical manufacturing, particle size distribution directly affects drug product performance. The dissolution rate of a tablet, the content uniformity of a capsule, and the bioavailability of an API are all influenced by particle size. If the vibratory screener does not consistently deliver the specified particle size cut, the finished drug product may not meet its release specifications.
Achieving consistent particle size separation requires precise screen specification, proper screener operation (correct amplitude, frequency, and feed rate), and regular screen condition monitoring. Worn screens, screens with distorted openings, or screens that have been improperly tensioned will not deliver a consistent cut point. ScreenerKing replacement screens are manufactured to tight dimensional tolerances that support the precision pharmaceutical screening demands.
Validation, Documentation, and Regulatory Compliance
Every vibratory screener and screen used in pharmaceutical manufacturing must be documented, validated, and maintained within a quality system that satisfies FDA cGMP requirements (21 CFR Parts 210 and 211), USP general chapters, and for products distributed in Europe, EU GMP Annex 1 requirements for sterile manufacturing.
This documentation burden includes equipment qualification (IQ/OQ/PQ), cleaning validation, screen material certificates, calibration records, maintenance logs, and change control documentation. The screener must be qualified to operate within its specified range, and any change to the screen specification (mesh size, material, supplier) triggers a change control evaluation and potentially revalidation.
ScreenerKing supports pharmaceutical customers with material certifications, dimensional documentation, and traceability records that simplify the validation and change management process when transitioning to ScreenerKing replacement screens.
What Equipment Does Pharmaceutical Manufacturing Need?
Pharmaceutical vibratory screening equipment must combine precise separation performance with sanitary design, full material traceability, and construction that supports validated cleaning procedures. Equipment selection depends on the production scale, the type of pharmaceutical products being manufactured, and the facility's regulatory classification.
Recommended Screener Types
- Lab and R&D screening (18"): The SiftPro 18" serves pharmaceutical R&D labs, analytical screening, and small-scale formulation development where sample sizes are limited and cleaning between products must be fast and thorough.
- Pilot and small-batch production (18" – 24"): The SiftPro 18" and SiftPro 24" handle pilot-scale batches and small-volume production of specialty or orphan drug products where batch sizes are modest but precision requirements are absolute.
- Full-scale production (24" – 30"): The SiftPro 24" and SiftPro 30" serve high-volume oral solid dosage manufacturing lines for post-granulation sizing, excipient screening, and blend verification at production throughput rates.
- High-volume excipient and bulk pharma (48" – 60"): The SiftPro 48 and SiftPro 60 handle large-volume excipient processing, bulk pharmaceutical chemical manufacturing, and high-throughput granulation sizing operations.
Recommended Screen Specifications for Pharmaceutical Manufacturing
| Application | Recommended Screen Size | Mesh Range | Recommended Material | Screen Type |
|---|---|---|---|---|
| API classification | 18" – 30" | 60 – 325 mesh | 316 SS (electropolished) | Standard, ultrasonic for fine mesh |
| Excipient screening | 24" – 48" | 20 – 100 mesh | 316 SS | Standard or self-cleaning |
| Post-granulation sizing | 24" – 30" | 12 – 30 mesh | 316 SS | Standard |
| Safety screening | 24" – 48" | 10 – 30 mesh | 316 SS | Standard |
| Fine API / micronized powder | 18" – 24" | 200 – 325 mesh | 316 SS (electropolished) | Ultrasonic deblinding recommended |
| Liquid filtration (suspensions) | 18" – 30" | 100 – 325 mesh | 316 SS | Standard |
cGMP Compliance Requirements
Pharmaceutical vibratory screeners and screens must meet the following requirements to support cGMP compliance:
- All product contact surfaces in 316 stainless steel, electropolished to 20–25 Ra where specified
- Complete material traceability with heat lot numbers and material test reports (MTRs)
- FDA-approved gaskets and sealing materials with documented compliance
- Tool-free disassembly for validated cleaning and visual inspection of all product contact areas
- No product-trapping dead zones, crevices, or exposed adhesives in the product flow path
- CIP or WIP compatibility for operations that clean equipment in place
- Documentation packages to support IQ/OQ/PQ validation protocols
How Does ScreenerKing Serve the Pharmaceutical Industry?
ScreenerKing has supplied pharmaceutical manufacturing operations with replacement screens, complete screener units, and parts for more than three decades. We understand the unique requirements of pharmaceutical screening, from material traceability and documentation to the precision dimensional tolerances that validated screening processes demand.
Compatible Replacement Screens
We manufacture replacement screens in 316 stainless steel compatible with the vibratory separators most commonly installed in pharmaceutical facilities, including units from Sweco, Kason, Russell Finex, and Midwestern Industries. Our pharmaceutical-grade screens are available with material certifications and documentation to support your quality system requirements.
Complete Screener Units
Our SiftPro vibratory screener line is available in configurations suitable for pharmaceutical manufacturing, with 316 SS construction, sanitary design options, and documentation packages for equipment qualification. From R&D lab screening to full-scale production, we supply the right unit for your pharmaceutical operation.
Parts and Accessories
We stock pharmaceutical-compatible parts including FDA-approved gaskets in silicone and EPDM, springs and spools, frames, de-blinding systems, and vibratory motors. Having one reliable source for all your screening consumables reduces procurement complexity and helps maintain consistent quality across your screening operations.
Pharmaceutical Screening FAQs
What mesh sizes are used for pharmaceutical powder screening?
Mesh sizes vary by application. API classification typically uses 60 to 325 mesh (250 to 45 microns). Excipient screening commonly uses 20 to 100 mesh (850 to 150 microns). Post-granulation sizing uses 12 to 30 mesh (1,700 to 600 microns). The specific mesh is determined by the product formulation and must be validated as part of the manufacturing process. Use our pharmaceutical mesh size guide for detailed recommendations.
What is the difference between cGMP and GMP for pharmaceutical screeners?
GMP refers to the general Good Manufacturing Practice standards. cGMP (current Good Manufacturing Practice) is the FDA's term emphasizing that manufacturers must use up-to-date systems and technologies. Pharmaceutical screeners must comply with cGMP under 21 CFR Parts 210 and 211, which mandate documented cleaning procedures, validated processes, material traceability, and equipment designed to prevent contamination.
Do pharmaceutical vibratory screeners need to be validated?
Yes. Vibratory screeners used in pharmaceutical manufacturing must undergo Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ). This confirms the screener is installed correctly, operates within specified parameters, and consistently produces product meeting quality specifications. All documentation must be maintained for regulatory inspections.
Why is 316 stainless steel required for pharmaceutical screens?
316 stainless steel is required because of its superior corrosion resistance against the aggressive cleaning agents and solvents used in pharmaceutical manufacturing. The molybdenum in 316 SS provides better resistance to pitting and crevice corrosion than 304 SS. This prevents metal contamination and ensures screen integrity through repeated chemical cleaning cycles.
Can vibratory screeners be used in cleanroom environments?
Yes. Vibratory screeners designed for pharmaceutical use can operate in cleanrooms when they meet specific requirements: all-stainless construction with electropolished surfaces, sealed motor housings, gaskets rated for the cleanroom classification, and CIP or WIP capability. The screener must not generate particulate contamination above the cleanroom classification threshold.
How do you prevent cross-contamination between pharmaceutical batches?
Cross-contamination prevention requires a validated cleaning procedure between batches: complete disassembly, screen removal and inspection or replacement, cleaning all product contact surfaces with validated agents, swab or rinse testing to verify effectiveness, and full documentation. Many operations use dedicated screens for each product to eliminate screen-to-product cross-contamination risk.
Ready to Improve Your Pharmaceutical Screening Operation?
Whether you need 316 SS replacement screens for your existing Sweco or Russell Finex separator, a new screener unit for a pharmaceutical production line, or documentation support for a validation project, ScreenerKing delivers pharmaceutical-grade quality with the fastest lead times in the industry. Over 30 years of pharmaceutical screening experience. Made in USA.
Request a Quote Shop 316 SS Screens Contact Our Team